1.8460
+0.0120
+(0.65%)
At close: April 17 at 9:55:01 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
149,011
136,561
250,393
246,383
Total Liabilities Net Minority Interest
82,084
49,946
105,596
81,992
Total Equity Gross Minority Interest
66,927
86,615
144,797
164,391
Total Capitalization
95,832
86,615
144,797
164,391
Common Stock Equity
66,927
86,615
144,797
164,391
Capital Lease Obligations
30,990
16,024
43,638
47,654
Net Tangible Assets
64,464
84,152
141,556
161,150
Working Capital
75,124
57,636
113,828
128,517
Invested Capital
95,832
86,615
144,797
164,391
Tangible Book Value
64,464
84,152
141,556
161,150
Total Debt
59,895
16,024
43,638
47,654
Net Debt
9,641
--
--
--
Share Issued
81,850
69,905
65,811.3180
65,109
Ordinary Shares Number
81,850
69,905
65,811.3180
65,109
12/31/2021 - 5/23/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4AJ0.BE Alk-Abello A/S
19.68
+2.23%
8C5.F Coherus BioSciences, Inc.
0.8802
-4.37%
CXF.F Chimerix, Inc.
7.48
+0.27%
ITH.F Nektar Therapeutics
0.5740
+5.03%
I5X.F Precigen, Inc.
1.1700
-2.42%
LEXXW Lexaria Bioscience Corp.
0.3400
-8.11%
IPIX Innovation Pharmaceuticals Inc.
0.0002
0.00%
NEUP Neuphoria Therapeutics Inc.
5.14
+0.38%
TSVT 2seventy bio, Inc.
4.9800
+0.20%
AEON AEON Biopharma, Inc.
0.4050
+1.28%